Search Results - Stephen Forman
- Showing 1 - 5 results of 5
-
1
Oligo-PROTAC strategy for cell-selective and targeted degradation of activated STAT3 by Jeremy Hall, Zhuoran Zhang, Supriyo Bhattacharya, Dongfang Wang, Marice Alcantara, Yong Liang, Piotr Swiderski, Stephen Forman, Larry Kwak, Nagarajan Vaidehi, Marcin Kortylewski
Published in Molecular Therapy: Nucleic Acids (2024-03-01)Get full text
Article -
2
Prognostic significance of B-cells and pSTAT3 in patients with ovarian cancer. by Chunmei Yang, Heehyoung Lee, Veronica Jove, Jiehui Deng, Wang Zhang, Xueli Liu, Stephen Forman, Thanh H Dellinger, Mark Wakabayashi, Hua Yu, Sumanta Pal
Published in PLoS ONE (2013-01-01)Get full text
Article -
3
P111: Phase I Trial of Brentuximab Vedotin plus Cyclosporine in Relapsed/Refractory Hodgkin Lymphoma by Swetha Kambhampati, Matthew Mei, Lu Chen, Sandrine Puvurel, Robert Chen, Leslie Popplewell, Liana Nikolaenko, Lacolle Peters, Saro Armenian, Larry Kwak, Steven T. Rosen, Stephen Forman, Alex F. Herrera
Published in HemaSphere (2022-10-01)Get full text
Article -
4
P112: Phase II Trial of Brentuximab Vedotin plus ibrutinib in Relapsed/Refractory Hodgkin Lymphoma by Matthew Mei, Joycelynne Palmer, Kami Maddocks, Peter Martin, Ni-Chun Tsai, Eileen Smith, Leslie Popplewell, Saro Armenian, Geoffrey Shouse, Robert Chen, Larry Kwak, Steven T. Rosen, Stephen Forman, David Bond, Alex F. Herrera
Published in HemaSphere (2022-10-01)Get full text
Article -
5
Use of monoclonal antibody therapy in hematologic patients with mild‐to‐moderate COVID‐19: A retrospective single‐center experience by Idoroenyi Amanam, Janny Yao, Alfredo Puing, Ni‐Chun Tsai, Diana Samuels, Dat Ngo, Stephanie Ho, Haris Ali, Ahmed Aribi, Shukaib Arslan, Andrew Artz, Myo Htut, Paul Koller, Amandeep Salhotra, Karamjeet Sandhu, Liana Nikolaenko, Anna Pawlowska, Geoffrey Shouse, Anthony Stein, Guido Marcucci, Stephen Forman, Ryotaro Nakamura, Sanjeet Dadwal, Monzr M. Al Malki
Published in Cancer Medicine (2023-05-01)Get full text
Article